Accorto Regulatory Solutions
Chris Robinson is a highly experienced regulatory professional with a solid background in the pharmaceutical and medical device industries. Currently serving as a Senior Regulatory Writer at Accorto Regulatory Solutions since April 2022, Chris manages various activities related to CMC sections for regulatory submissions, including authoring and reviewing documents. Previously, Chris held the position of Director of Research Development at Exela Pharma Sciences, leading a team to support CMC sections of ANDA/NDA filings for sterile injectable drug products. Additional experience includes positions as Associate Director of R&D at Ei Solutionworks and Manager of Launch Analytics and Sr. Manager of R&D at Boehringer Ingelheim, overseeing teams and enhancing laboratory efficiency. Chris holds both a Master’s and Bachelor’s degree in Chemistry from the University of North Carolina at Wilmington.
This person is not in any teams
Accorto Regulatory Solutions
At Accorto Regulatory Solutions, we help small to mid-sized domestic and international companies take their FDA regulated products to market through innovative and cost-effective regulatory application strategies, and then work with them to keep their products on the market through a focus on regulatory compliance. The FDA has its own culture, processes, and labyrinth of hurdles that are all put in place to protect public health, but to entrepreneurs, small companies without an in-house regulatory staff, or overseas companies trying to crack the US market, this can seem impossibly daunting. Accorto can help you understand the process and guide you through a feasible path to being granted marketing authority.